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Abstract: In the 1950s the myxoma virus was released into European rabbit 62 
populations in Australia and Europe, decimating populations and resulting in the rapid 63 
evolution of resistance. We investigated the genetic basis of resistance by comparing 64 
the exomes of rabbits collected before and after the pandemic. We found a strong 65 
pattern of parallel evolution, with selection on standing genetic variation favouring 66 
the same alleles in Australia, France and the United Kingdom. Many of these changes 67 
occurred in immunity-related genes, supporting a polygenic basis of resistance. We 68 
experimentally validated the role of several genes in viral replication and showed that 69 
selection acting on an interferon protein has increased its antiviral effect.  70 
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Main Text: The emergence of new infectious diseases can result in intense selective 71 
pressures on populations and cause rapid evolutionary change in both host and 72 
parasite. While pathogens must adapt to a new ecology and cellular environment, 73 
hosts can rapidly evolve resistance in a continuous arms-race. One of the most 74 
emblematic examples of this coevolutionary process arose when the wild European 75 
rabbit (Oryctolagus cuniculus) populations in Australia and Europe were exposed for 76 
the first time to the myxoma virus (MYXV; genus Leporipoxvirus, family 77 
Poxviridae). MYXV circulates naturally in American cottontail rabbits (Sylvilagus 78 
spp.) where it causes benign skin tumours, but in European rabbits it causes the highly 79 
lethal systemic disease myxomatosis (1). 80 
Rabbits were initially introduced into Australia by European settlers, resulting in 81 
extensive ecological and economic damage (2). In an attempt to control the rabbit 82 
populations, MYXV was released in 1950 in Australia, after which it spread rapidly 83 
across the country, causing massive population reductions (1). In 1952 it was released 84 
in France and in 1953 it reached the United Kingdom (UK) with similar outcomes (2). 85 
In a series of classic experiments, the evolution of the virus and rabbits was tracked, 86 
and in all three countries substantial declines in case fatality rates in wild rabbits were 87 
observed both due to evolution of less virulent viral phenotypes and increased 88 
resistance in rabbit populations (3-5). Considered ³one of the greatest natural 89 
experiments in evolution´, these observations ultimately became a textbook example 90 
of host-parasite coevolution (2). 91 
Sixty-nine years have passed since myxomatosis was first released in Australia and 92 
today the virus continues to evolve in an ongoing arms-race against the rabbit immune 93 
system (6, 7). Despite much research on the genetics of MYXV, little is known about 94 
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the genetic basis of resistance to myxomatosis. The intense selective pressure exerted 95 
by the disease in rabbits and the parallel phenotypic evolution across multiple 96 
populations, provides an exceptional framework to study the evolution of resistance to 97 
a highly lethal pandemic in natural host populations. To understand the genetic basis 98 
of these changes we focused on three countries where genetic resistance 99 
independently emerged: Australia, France and the UK. For each one, we compared 100 
modern rabbits with historical specimens from museums that were collected before or 101 
soon after the release of the virus (1856-1956; Figs. 1 and S1, File S1). 102 
Colonisation route of rabbits  103 
To obtain genome-wide polymorphism data we used oligonucleotide probes to 104 
capture 32.10Mb (1.17%) of the rabbit genome that includes the exome (19,293 105 
genes), the mitochondrial genome, and three genomic regions that contain the Major 106 
Histocompatibility Complex region (MHC) encompassing 1.75 Mb. We sequenced 107 
152 rabbits from Australia (historical: n=17, modern: n=26), France (historical: n=29, 108 
modern: n=26) and the UK (historical: n=29, modern: n=25). The mean sequence 109 
coverage on-target per individual after filtering was 33X. After filtering, the number 110 
of bi-allelic SNPs was 757,333.  111 
Historical records support the introduction of rabbits to the UK mainland from 112 
continental Europe by the 13
th
 century (8) and most Australian rabbits are thought to 113 
be derived from an introduction in 1859 from the UK (9) (Fig. 1). Our genetic data 114 
reflects these historical records. Both Principal Components Analysis (PCA; Fig. 2a) 115 
and structure analyses (Fig. 2b; K=3) reveal three clusters composed of individuals 116 
from the same country. The sequential colonisation from France to the UK and then 117 
Australia is reflected in the levels of genetic differentiation which are greatest 118 
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between France and Australia, and lowest between UK and Australia (Table S1). This 119 
pattern is repeated with the Australian populations clustering together with the UK in 120 
the structure analysis (Fig. 2b; K=2). Population bottlenecks during colonisation can 121 
reduce genetic diversity and increase linkage disequilibrium (LD). Both aspects are 122 
reflected in the successive increases in LD (Fig. 2c) and decreases in heterozygosity 123 
(Fig. 2d) as rabbits moved from continental Europe to the UK and then Australia.  124 
Genetic variation in historical and modern populations  125 
To detect changes in allele frequency due to natural selection, it is important that the 126 
genome-wide allele frequencies in our modern and historical samples are similar. 127 
Although changes in allele frequency are an expected signal of selection, artefactual 128 
variation generated by DNA degradation can generate similar signals between modern 129 
and historical DNA. To mitigate this, we sequenced samples to a high coverage, 130 
corrected for the effects of DNA damage patterns, and used a stringent set of filters at 131 
read and variant level. Genome-wide differences in allele frequency between our 132 
modern and historical samples could also arise due to population substructure. To 133 
minimise this effect, we sampled modern rabbits from locations near to where the 134 
historical specimens had been sampled (Figs. 1 and S1).  135 
We consistently found that historical and modern populations from the same country 136 
exhibit similar patterns of genetic structure and diversity. In the PCA, the 95% 137 
confidence ellipses for historical and modern samples from the same country are 138 
interspersed (Fig. 2a). In the structure analysis, the patterns again reflect geography 139 
rather than the time of sampling (Fig. 2b, K=3), and increasing the number of 140 
ancestral populations (K) reveals finer population substructure instead of a split 141 
between the different time points (Fig. S2). More generally, across all SNPs the allele 142 
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frequencies of historical and modern populations are highly correlated in the three 143 
countries (Fig. 2e).  144 
The collapse of populations due to myxomatosis has not increased levels of LD or 145 
decreased genetic diversity as both these parameters are similar between historical 146 
and modern populations (Figs. 2c and 2d). This is to be expected as the effective 147 
population size of rabbits is ~10
6
 (10)
 
, which is large for a vertebrate. Therefore, even 148 
if an ~99% reduction in population size (as seen in some populations immediately 149 
after the first epidemic (6)), had been sustained for the subsequent 65 generations, the 150 
expected reduction in heterozygosity would have only been 0.35% (per generation 151 
reduction heterozygosity = 1-1/(2Ne)). Similarly, bottlenecks of this size are expected 152 
to have little effect on LD (11). Together, these results demonstrate that historical and 153 
modern samples are drawn from genetically similar populations. This strong 154 
correlation in allele frequencies between the two time points within each country is 155 
conducive to the identification of unusual shifts in allele frequency resulting from 156 
natural selection. 157 
Parallel changes in allele frequency  158 
With a 99.8% case fatality rate of the originally released strain of MYXV, the 159 
myxomatosis pandemic imposed intense selection on rabbits, resulting in rapid and 160 
parallel evolution of increased resistance in exposed populations (6). To investigate 161 
whether parallel genetic changes occurred in Australia, France and the UK, we 162 
calculated FST between the historical and modern samples for each country and 163 
identified the 1000 SNPs that show the highest FST. By intersecting these three lists 164 
we found that more alleles have changed in frequency across two or three countries 165 
than expected by chance (Fig. 3a; File S2). Furthermore, considering the 92 SNPs in 166 
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the intersections of Fig. 3a, in 87 cases it was the same allele that had increased in 167 
frequency in the countries involved. It is particularly striking that SNPs that were 168 
among the top 1000 most differentiated in any two populations tend to show elevated 169 
FST in the third population (Fig. 3b). These results demonstrate the occurrence of 170 
parallel changes in allele frequency across the three populations. 171 
To locate the putative targets of selection in the genome, we searched for SNPs that 172 
experienced large changes in allele frequency since the release of the MYXV. We 173 
accounted for the effects of population structure by scanning for outliers where the 174 
difference in allele frequency between modern and historical populations was larger 175 
than expected given the covariance matrix describing the joint allelic frequencies 176 
among populations inferred from the structure analysis (Fig. 2b, K=3). In each 177 
population, we assumed selection started in the year the virus was introduced. For 178 
each SNP, we then compared the likelihood of a model where the change in allele 179 
frequency followed that predicted from the genome-wide amount of genetic drift 180 
across all historical and modern samples to a model that allowed additional changes in 181 
allele frequency through time (Fig. S3).  Combining data across the three populations 182 
and allowing the strength of selection to vary independently in the three countries, we 183 
identified 193 SNPs in 98 genes and 7 intergenic regions that experienced significant 184 
changes in allele frequency (genome-wide significance p<0.05; Fig. 3c; File S3. The 185 
results were similar when we assumed the same strength of in all countries (Fig. S4; 186 
File S3). 187 
To explicitly test for parallel evolution and identify variants that significantly changed 188 
in frequency in all three populations, we compared the likelihood of our previous 189 
model, that assumed the equal selection across the three populations, to a model 190 
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where we allowed the alleles to change in frequency due to selection in one 191 
population only. We identified 94 SNPs that had a significant signature of parallel 192 
selection (genome-wide significance p<0.05; Fig. 3d, positive values).  193 
It is common to find considerable standing genetic variation in susceptibility to 194 
infection within populations (12, 13), which may allow populations to rapidly evolve 195 
resistance when they encounter novel pathogens (14). This can be explicitly tested 196 
with our experimental design that incorporated historical samples. We found that in 197 
the large majority of cases, the SNPs under selection were also present in at least one 198 
of our historical populations (93% and 84% of the SNPs with a genome-wide P<0.05 199 
in Figs. 3c and 3d, respectively). Therefore, parallel evolution has occurred because 200 
natural selection has been acting on standing genetic variation that was present over 201 
800 years ago in continental Europe, and was carried with rabbits to the UK and 202 
Australia. The existence of this variation likely explains the rapid development of 203 
resistance to myxomatosis observed almost immediately after the first outbreaks. 204 
Population-specific evolution  205 
Despite the common selection pressure imposed by myxomatosis, the populations of 206 
France, UK and Australia will have experienced their unique selection pressures, as 207 
resistance was evolving in a different ecological and genetic background. We can 208 
identify SNPs that have experienced population-specific changes in allele frequency 209 
from our previous analysis when the model of selection in one population is preferred 210 
over the model of selection in all three populations (negative values in Fig. 3d).  211 
To quantify the proportion of SNPs under parallel or population-specific selection we 212 
used a Bayesian approach. First, we analysed data from each population 213 
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independently to identify variants under selection (Fig. S5, File S4; genome-wide 214 
p<0.05). This minimises the inherent bias towards detecting SNPs under parallel 215 
selection that occurs when the all populations are combined (Figs. 3c and 3d). We 216 
then returned to the combined dataset, and for each of the SNPs that were significant 217 
in the single population analysis we calculated a Bayes factor to compare models of 218 
population-specific versus parallel selection (Fig. S5). For each gene we retained only 219 
the most significant SNP (n=43, File S5). We found evidence that 20 SNPs were 220 
under population-specific and 20 were under parallel selection (for 3 SNPs we could 221 
not distinguish the models), implying that a large component of the recent selection in 222 
the three populations has occurred on a common set of variants.  223 
Due to population bottlenecks as rabbits colonised new areas (Figs. 2c and 2d),  224 
alleles selected in one population may be rare or missing in other populations. This 225 
means that population-specific adaptation could result not just from differences in 226 
selection pressures but also due to differences in the variants available for selection to 227 
act on. To test this, we examined the frequency of the 20 alleles under population-228 
specific selection in our historical samples. There were no consistent differences in 229 
the ancestral allele frequencies between the populations where we detected the effects 230 
of selection and populations where we did not (Table S2). Therefore, we can conclude 231 
that population-specific changes in allele frequency result from population-specific 232 
selection pressures, perhaps due to differences in ecology, genetic background or 233 
independent paths of co-evolution with MYXV (15). 234 
Changes in the strength of selection  235 
The proportion of rabbits killed by myxomatosis has fallen since the 1950s, due to 236 
declines in the virulence of the virus and increases in resistance (6). Therefore, the 237 
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strength of selection on variants that confer resistance to MYXV is expected to have 238 
declined. However, in 1984 a new lethal viral pathogen was identified in rabbits, the 239 
rabbit haemorrhagic disease virus (RHDV; genus Lagovirus, family Caliciviridae) 240 
(16). RHDV, which has a similar case-fatality rate to myxomatosis, was first found in 241 
domestic rabbits in China, from where it spread to continental Europe in 1986, the 242 
UK in 1992 and Australia in 1995 (2, 17, 18). Like myxomatosis, RHDV caused high 243 
mortality across the two continents, which could have contributed to the observed 244 
changes in allele frequency.  245 
To evaluate the role of RHDV in our selection signatures and understand how the 246 
strength of selection has changed through time, we obtained 70 rabbit samples that 247 
were collected before or soon after RHDV between 1985 and 1996, in the UK and 248 
Australia (Fig. 3e: File S1). We selected four SNPs that had experienced significant 249 
changes in allele frequency since the 1950s and that were located in or near genes 250 
with known immune functions (CD96, FCRL3, IFN-Į$ and MHC Class I), and 251 
genotyped them in these samples by Sanger sequencing. Combining these genotypes 252 
with data from our exome sequences, we used a Bayesian approach (19) to estimate 253 
the selection coefficient acting on these SNPs. We allowed two phases of selection. 254 
The first from when MYXV was released to the appearance of RHDV, and the second 255 
from the appearance of RHDV to the present day (Fig. 3e; note the date when the 256 
strength of selection changes is fixed in the model).  257 
We found that the strength of selection on FCRL3 and IFN-Į$ has declined 258 
through time in both the UK and Australia (Fig. 3e, File S6). This is consistent with 259 
selection being driven by MYXV, whose case fatality rate has decreased since its 260 
release, and does not support a role for RHDV. Intriguingly, the data suggests that 261 
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these variants have been negatively selected in recent decades (Fig. 3e), which is 262 
predicted if they have negative pleiotropic costs on other fitness components. For 263 
CD96 and MHC, there was no significant change in the strength of selection through 264 
time (File S6). Nonetheless, both the genes in the UK and CD96 in Australia have a 265 
significant signal of positive selection before the release of RHDV.  266 
We observed large changes in allele frequency across the two time periods (Fig. 3e). 267 
Averaging across populations during the first phase of selection, we estimate the per 268 
year selection coefficient was 0.16 for IFN-Į$0.13 for FCRL3, 0.08 for CD96 and 269 
0.07 for MHC (File S6). These analyses assume the alleles were additive, but 270 
estimates of the timing and strength of selection remained similar if we assumed 271 
recessive or dominant mode of inheritance. 272 
Selection on the immune system 273 
The innate immune response provides the first line of defence against viruses. It is 274 
activated by the secretion of cytokines including interferon-Į,)1-Į, which binds to 275 
receptors on uninfected neighbouring cells and induces an antiviral state. To 276 
circumvent this, MYXV encodes potent inhibitors of the interferon response, 277 
including the double-stranded RNA binding protein M029 (20, 21). Among the most 278 
significant increases in frequency in our dataset, there are three non-synonymous 279 
variants that segregate as a haplotype in the interferon-Į21A gene (IFN-Į$; Fig. 280 
3c). To evaluate the role of these SNPs in the antiviral activity of IFN-Į$, we 281 
synthesised the two corresponding protein isoforms and tested their antiviral effect by 282 
measuring MYXV viral replication in a rabbit cell line. Neither isoform of IFN-Į$ 283 
affected the replication of the wild-type MYXV (Lausanne strain) (Fig. S6a), however 284 
both reduced significantly the replication of an attenuated strain of MYXV (M029 285 
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mutant) (22) (Figs. 4a and S6b). Moreover, we found that the isoform of IFN-Į$ 286 
(varIFN-Į$) that had been favoured by selection more strongly inhibited the 287 
replication of M029 MYXV. This indicates that natural selection has increased the 288 
potency of the interferon response in modern rabbit populations that have co-evolved 289 
with MYXV. The selected allele also had an antiviral effect on vesicular stomatitis 290 
virus (VSV), an RNA virus (Fig. 4b). This suggests a general increase in the protein¶s 291 
antiviral activity and it may be that selection by MYXV has increased resistance to 292 
other viruses, including RHDV. While this effect was not apparent with wild-type 293 
MYXV, this could be a limitation of the cell culture-based experiment, since in vivo 294 
innate immune responses involve the coordinated action of multiple cytokines across 295 
many tissues. In such circumstances, it is possible that the isoform of IFN-Į$ that 296 
has been favoured by selection may contribute to attenuating wild-type MYXV 297 
infection. 298 
We found a strong population-specific signal of selection on a non-synonymous 299 
variant in CD200-R, which is the receptor for the negative regulator of innate immune 300 
responses CD200. The selected allele was not observed in any of the historical 301 
populations, but it increased to a frequency of 56% in the modern French population 302 
(Fig. 3d). The selected residue is part of the CD200 binding interface (23) (Fig. S7). 303 
Mutation of this site in the human protein does not prevent CD200 binding (24), but it 304 
may affect binding affinity in a quantitative way. Therefore, any effects of this variant 305 
may occur via modulation of the rabbit CD200:CD200R interaction.  306 
Alongside the innate immune response, hosts mount an adaptive antiviral immune 307 
response mediated by MHC class I proteins. Polymorphisms in the peptide-binding 308 
region of MHC proteins affect the repertoire of peptides they can present and are 309 
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frequently associated with variation in susceptibility to infectious disease (25). We 310 
found multiple SNPs in the MHC region that have experienced positive selection 311 
across the three populations (Fig. 3c). However, the top hits in this region were 312 
located in an intergenic region of 35.7Kb between two MHC class I genes (grey 313 
shaded box; Fig. 3c). We failed to sequence the regions encoding the peptide-binding 314 
regions of these proteins for most individuals (either the sequence capture or read 315 
mapping failed). Therefore, the variants that have increased in frequency in the 316 
intergenic region may be in LD with variants in the protein coding sequence that 317 
affect susceptibility to MYXV.  318 
Other immunity genes that exhibit parallel changes in frequency include four non-319 
synonymous variants in FCRL3 (Fc Receptor-Like 3), a cell surface receptor that 320 
inhibits the activation of B cells (26). Three highly significant non-synonymous 321 
variants are in CD96 which is a transmembrane receptor of T and NK cells involved 322 
in modulating immune responses (27, 28). The four SNPs with the highest likelihood 323 
in the entire dataset were all intronic variants present in the MFSD1, which encodes a 324 
transmembrane protein in the major facilitator superfamily. Several paralogs of this 325 
gene have been identified in a genome-wide RNAi screen for genes affecting 326 
replication of vaccinia virus, a poxvirus related to MYXV (29). Using RNAi, we 327 
found that this gene also modulated MYXV titres in rabbit cells (Fig. S6e). 328 
Selection on proviral genes  329 
Resistance to viruses can evolve not only through improvement of antiviral defences, 330 
but also through changes in host proviral proteins that viruses hijack for their own 331 
benefit. Among our significant associations was a SNP LQWKH¶SULPH875 of VPS4 332 
(Fig. 3c). This gene has no known role in the replication cycle of poxviruses, but is 333 
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required for the envelopment of herpes simplex virus (HSV) in the cytoplasm (30). To 334 
evaluate the role of VPS4 in MYXV replication we took advantage of a human cell 335 
line expressing a dominant-negative form of the VPS4 protein (30). By comparing the 336 
effect of MYXV in wild-type and VPS4 dominant-negative human cell lines, we 337 
found that the latter strongly inhibited MYXV replication (Figs. 4c, 4d, S6c and S6d). 338 
In contrast to HSV, the effect at a high multiplicity of infection suggests VPS4 may 339 
affect earlier replication steps in MYXV. Therefore, the VPS4 protein is proviral, and 340 
it is possible that selection by MYXV may have altered its expression in the modern 341 
rabbit populations. 342 
The proteasome is required both for poxvirus uncoating after the cell entry (31) and 343 
the processing of antigenic peptides, and three variants in the gene PSMG3 (pac3, 344 
proteasome assembly chaperone 3) increased 83% in frequency in France, with 345 
smaller changes in other populations. Using Sanger sequencing we found that these 346 
SNPs were associated with a 7-base pair insertion in the first exon and a 50-base pair 347 
deletion spanning the first intron and second exon. However, since genome annotation 348 
of this gene is incomplete the importance of these changes is unclear.  349 
Conclusions: The myxomatosis pandemic caused massive mortality in rabbit 350 
populations, leading to the evolution of genetic resistance to the disease in Australia, 351 
France and the UK. We have found that over the last 60 years, the convergent 352 
phenotype of viral resistance in these populations was also accompanied by parallel 353 
genetic changes. This was a consequence of natural selection acting on standing 354 
genetic variation that was present in the ancestral rabbit populations in continental 355 
Europe and was retained in the subsequent colonisation process of the UK and 356 
Australia. The presence of this variation likely explains the rapid development of 357 
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resistance to myxomatosis observed in rabbit populations almost immediately after 358 
the first outbreaks and may frequently be critical to allow populations to respond to 359 
novel pathogens. This is in striking contrast to the evolution of the virus where 360 
parallel changes in MYXV virulence do not have a common genetic basis (15). 361 
Despite rapid phenotypic evolution, only 1% of the alleles favoured by selection have 362 
reached fixation in any of the modern populations (Fig. 3c, 3 out of 193 SNPs). 363 
Together with our estimates of selection coefficients and the moderate antiviral effect 364 
of the three interferon SNPs, this suggests genetic resistance to myxomatosis is a 365 
polygenic trait resulting from the cumulative effect of multiple alleles shifting in 366 
frequency across the genome, as opposed to a few major-effect changes to the 367 
immune response. 6XFKDGDSWDWLRQLVOLNHO\WRUHVXOWLQDJUDGXDOµTXDQWLWDWLYH¶368 
increase in resistance. When resistance reduces the within±host replication rate of the 369 
virus rather than completely preventing infection, selection will favour increases in 370 
viral virulence (32). Consistent with this prediction, it has recently been observed in 371 
wild populations of rabbits that the decline in virulence seen in the years immediately 372 
after the virus was released has been reversed and highly virulent viral genotypes 373 
have emerged (7). 374 
The evolution of resistance to MYXV is associated with enhanced innate antiviral 375 
immunity (6). Homologs of CD96, FCRL, CD200-R and IFN-Įall play a regulatory 376 
role in the innate immune response, including effects on lymphocyte proliferation and 377 
activation (21, 26, 27, 33). The increased virulence seen in recent MYXV isolates is 378 
associated with the virus becoming extremely immunosuppressive, causing the loss of 379 
cellular inflammatory responses, lymphocytes and neutrophils (7). Therefore, viral 380 
evolution may have found ways to counter the effect of many of the genetic 381 
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adaptations that we have observed.  In conclusion, our results reveal how standing 382 
genetic variation in the immune system allowed populations to rapidly evolve 383 
resistance to a novel and highly virulent pathogen and describe the molecular and 384 
genetic basis of an iconic example of natural selection.  385 
!18 
!
 
References and Notes: 386 
 387 
1. F. Fenner, F. N. Ratcliffe, Myxomatosis (Cambridge University Press, 388 
Cambridge ; New York, 1965). 389 
2. F. Fenner, B. Fantini, Biological Control of Vertebrate Pests: The History of 390 
Myxomatosis - an Experiment in Evolution. (CABI publishing, New York, NY, 391 
USA, 1999). 392 
3. J. Ross, M. F. Sanders, The development of genetic resistance to myxomatosis 393 
in wild rabbits in Britain. J Hyg (Lond). 92, 255±261 (1984). 394 
4. F. Fenner, J. Ross, in The European rabbit: The History and Biology of a 395 
Successful Colonizer, H. V. Thompson, C. M. King, Eds. (Oxford University 396 
Press, Oxford ; New York, 1994), pp. 205±239. 397 
5. I. D. Marshall, F. Fenner, Studies in the epidemiology of infectious 398 
myxomatosis of rabbits. V. Changes in the innate resistance of Australian wild 399 
rabbits exposed to myxomatosis. J Hyg (Lond). 56, 288±302 (1958). 400 
6. P. J. Kerr, Myxomatosis in Australia and Europe: a model for emerging 401 
infectious diseases. Antiviral Res. 93, 387±415 (2012). 402 
7. P. J. Kerr et al., Next step in the ongoing arms race between myxoma virus and 403 
wild rabbits in Australia is a novel disease phenotype. Proc Natl Acad Sci USA. 404 
114, 9397±9402 (2017). 405 
8. E. M. Veale, The Rabbit in England. Agric Hist Rev. 5, 85±90 (1957). 406 
9. K. Myers, I. Parer, P. Wood, B. D. Cooke, in The European rabbit: The 407 
History and Biology of a Successful Colonizer, H. V. Thompson, C. M. King, 408 
Eds. (Oxford University Press, Oxford ; New York, 1994), pp. 108±157. 409 
10. M. Carneiro, N. Ferrand, M. W. Nachman, Recombination and speciation: loci 410 
near centromeres are more differentiated than loci near telomeres between 411 
subspecies of the European rabbit (Oryctolagus cuniculus). Genetics. 181, 593±412 
606 (2009). 413 
11. L. Kruglyak, Prospects for whole-genome linkage disequilibrium mapping of 414 
common disease genes. Nat Genet. 22, 139±144 (1999). 415 
12. A. V. S. Hill, Evolution, revolution and heresy in the genetics of infectious 416 
disease susceptibility. Phil. Trans. R. Soc. B. 367, 840±849 (2012). 417 
13. M. M. Magwire et al., Genome-wide association studies reveal a simple 418 
genetic basis of resistance to naturally coevolving viruses in Drosophila 419 
melanogaster. PLoS Genet. 8, e1003057 (2012). 420 
14. J. C. Stephens et al., Dating the origin of the CCR5-Delta32 AIDS-resistance 421 
allele by the coalescence of haplotypes. Am. J. Hum. Genet. 62, 1507±1515 422 
(1998). 423 
!19 
!
 
15. P. J. Kerr et al., Evolutionary history and attenuation of myxoma virus on two 424 
continents. PLoS Pathog. 8, e1002950 (2012). 425 
16. J. Abrantes, W. van der Loo, J. Le Pendu, P. J. Esteves, Rabbit haemorrhagic 426 
disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review. Vet 427 
Res. 43, 12 (2012). 428 
17. H. E. Fuller, D. Chasey, M. H. Lucas, J. C. Gibbens, Rabbit haemorrhagic 429 
disease in the United Kingdom. Vet. Rec. 133, 611±613 (1993). 430 
18. J. P. Morisse, G. Le Gall, E. Boilletot, Hepatitis of viral origin in Leporidae: 431 
introduction and aetiological hypotheses. Rev Sci Tech. 10, 269±310 (1991). 432 
19. L. Loog et al., Inferring Allele Frequency Trajectories from Ancient DNA 433 
Indicates That Selection on a Chicken Gene Coincided with Changes in 434 
Medieval Husbandry Practices. Mol Biol Evol. 34, 1981±1990 (2017). 435 
20. */6PLWK-$6\PRQV$$OFDPÕғ3R[YLUXVHVLQWHUIering with interferon. 436 
Semin Immunol. 8, 409±418 (1998). 437 
21. C. Upton, K. Mossman, G. McFadden, Encoding of a homolog of the IFN-438 
gamma receptor by myxoma virus. Science. 258, 1369±1372 (1992). 439 
22. M. M. Rahman, J. Liu, W. M. Chan, S. Rothenburg, G. McFadden, Myxoma 440 
virus protein M029 is a dual function immunomodulator that inhibits PKR and 441 
also conscripts RHA/DHX9 to promote expanded host tropism and viral 442 
replication. PLoS Pathog. 9, e1003465 (2013). 443 
23. D. Hatherley, S. M. Lea, S. Johnson, A. N. Barclay, Structures of 444 
CD200/CD200 receptor family and implications for topology, regulation, and 445 
evolution. Structure. 21, 820±832 (2013). 446 
24. D. Hatherley, A. N. Barclay, The CD200 and CD200 receptor cell surface 447 
proteins interact through their N-terminal immunoglobulin-like domains. Eur. 448 
J. Immunol. 34, 1688±1694 (2004). 449 
25. A. L. Hughes, M. Yeager, Natural selection at major histocompatibility 450 
complex loci of vertebrates. Annu. Rev. Genet. 32, 415±435 (1998). 451 
26. Y. Kochi et al., FCRL3, an autoimmune susceptibility gene, has inhibitory 452 
potential on B-cell receptor-mediated signaling. J. Immunol. 183, 5502±5510 453 
(2009). 454 
27. L. Martinet, M. J. Smyth, Balancing natural killer cell activation through paired 455 
receptors. Nat. Rev. Immunol. 15, 243±254 (2015). 456 
28. A. Fuchs, M. Colonna, The role of NK cell recognition of nectin and nectin-457 
like proteins in tumor immunosurveillance. Semin. Cancer Biol. 16, 359±366 458 
(2006). 459 
!20 
!
 
29. G. Sivan et al., Human genome-wide RNAi screen reveals a role for nuclear 460 
pore proteins in poxvirus morphogenesis. Proc Natl Acad Sci USA. 110, 3519±461 
3524 (2013). 462 
30. C. M. Crump, C. Yates, T. Minson, Herpes simplex virus type 1 cytoplasmic 463 
envelopment requires functional Vps4. J Virol. 81, 7380±7387 (2007). 464 
31. F. I. Schmidt et al., Vaccinia virus entry is followed by core activation and 465 
proteasome-mediated release of the immunomodulatory effector VH1 from 466 
lateral bodies. Cell Rep. 4, 464±476 (2013). 467 
32. S. Gandon, Y. Michalakis, Evolution of parasite virulence against qualitative or 468 
quantitative host resistance. Proc. Biol. Sci. 267, 985±990 (2000). 469 
33. G. Stack et al., CD200 receptor restriction of myeloid cell responses 470 
antagonizes antiviral immunity and facilitates cytomegalovirus persistence 471 
within mucosal tissue. PLoS Pathog. 11, e1004641 (2015). 472 
34. 5&RUH7HDP³5$/DQJXDJHDQG(QYLURQPHQWIRU6WDWLVWLFDO&RPSXWLQJ´5473 
Foundation for Statistical Computing., Vienna, Austria, 2015), (available at 474 
http://www.R-project.org/). 475 
35. 5$%HFNHU$5:LONV5%URZQULJJ730LQND³0DSVGUDZ476 
geographical maps. R package version 2.3-´ 477 
36. 5%URZQULJJ³0DSGDWD([WUD0DS'DWDEDVHV53DFNDJH9HUVLRQ-´478 
(2013). 479 
37. M. Meyer, M. Kircher, Illumina sequencing library preparation for highly 480 
multiplexed target capture and sequencing. Cold Spring Harbor Protocols. 481 
2010, pdb.prot5448 (2010). 482 
38. N. Wales et al., New insights on single-stranded versus double-stranded DNA 483 
library preparation for ancient DNA. BioTechniques. 59, 368±371 (2015). 484 
39. M. Carneiro et al., Rabbit genome analysis reveals a polygenic basis for 485 
phenotypic change during domestication. Science. 345, 1074±1079 (2014). 486 
40. S. Andrews, FastQC: a quality control tool for high throughput sequence data 487 
(2010), (available at http://www.bioinformatics.bbsrc. ac.uk/projects/fastqc). 488 
41. A. M. Bolger, M. Lohse, B. Usadel, Trimmomatic: a flexible trimmer for 489 
Illumina sequence data. Bioinformatics. 30, 2114±2120 (2014). 490 
42. J. Zhang, K. Kobert, T. Flouri, A. Stamatakis, PEAR: a fast and accurate 491 
Illumina Paired-End reAd mergeR. Bioinformatics. 30, 614±620 (2014). 492 
43. H. Li, R. Durbin, Fast and accurate short read alignment with Burrows-493 
Wheeler transform. Bioinformatics. 25, 1754±1760 (2009). 494 
44. I. M. H. Aaron R Quinlan, BEDTools: a flexible suite of utilities for comparing 495 
genomic features. Bioinformatics. 26, 841±842 (2010). 496 
!21 
!
 
45. A. W. Briggs et al., Patterns of damage in genomic DNA sequences from a 497 
Neandertal. Proc. Natl. Acad. Sci. U.S.A. 104, 14616±14621 (2007). 498 
46. H. Jónsson, A. Ginolhac, M. Schubert, P. L. F. Johnson, L. Orlando, 499 
mapDamage2.0: fast approximate Bayesian estimates of ancient DNA damage 500 
parameters. Bioinformatics. 29, 1682±1684 (2013). 501 
47. P. Danecek et al., The variant call format and VCFtools. Bioinformatics. 27, 502 
2156±2158 (2011). 503 
48. B. S. Weir, C. C. Cockerham, Estimating F-statistics for the analysis of 504 
population structure. Evolution. 38, 1358 (1984). 505 
49. B. Schwalb et al.3DFNDJH³/6'´ 506 
50. C. C. Chang et al., Second-generation PLINK: rising to the challenge of larger 507 
and richer datasets. GigaScience. 4, 7 (2015). 508 
51. J. K. Pritchard, M. Stephens, P. Donnelly, Inference of population structure 509 
using multilocus genotype data. 155, 945±959 (2000). 510 
52. J. Y. Cheng, T. Mailund, R. Nielsen, Fast admixture analysis and population 511 
tree estimation for SNP and NGS data. Bioinformatics. 33, 2148±2155 (2017). 512 
53. S. D. Turner, qqman: an R package for visualizing GWAS results using Q-Q 513 
and manhattan plots, 1±2 (2014). 514 
54. K. Soetaert, T. Petzoldt, R. W. Setzer, Solving differential equations in R: 515 
package deSolve. Journal of Statistical Software (2010). 516 
55. M. M. Rahman, G. McFadden, 517 
Myxoma Virus dsRNA Binding Protein M029 Inhibits the Type I IFN-518 
Induced Antiviral State in a  Highly Species-Specific Fashion. Viruses. 9 519 
(2017), doi:10.3390/v9020027. 520 
56. J. Liu et al., Myxoma virus expressing interleukin-15 fails to cause lethal 521 
myxomatosis in European rabbits. J Virol. 83, 5933±5938 (2009). 522 
57. F. J. Zemp et al., Treating brain tumor-initiating cells using a combination of 523 
myxoma virus and rapamycin. Neuro-oncology. 15, 904±920 (2013). 524 
58. F. Sievers et al., Fast, scalable generation of high-quality protein multiple 525 
sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539±539 (2011). 526 
59. C. S. Bond, A. W. Schüttelkopf, ALINE: a WYSIWYG protein-sequence 527 
alignment editor for publication-quality alignments. Acta Crystallogr. D Biol. 528 
Crystallogr. 65, 510±512 (2009). 529 
  530 
!22 
!
 
Acknowledgements: We thank the Australian Museum, American Museum of 531 
Natural History, Booth Museum of Natural History, Natural History Museum 532 
(London), Museum of Comparative Zoology (Harvard University), Musée des 533 
Confluences, Muséum National d'Histoire Naturelle (Paris), Museum Victoria, 534 
Queensland Museum, Museum of Zoology (University of Michigan), Smithsonian 535 
Institution National Museum of Natural History and all the curators and museum 536 
technicians who generously sampled and provided historical samples. Marie-537 
Dominique Wandhammer from Musée Zoologique de la Ville de Strasbourg that 538 
helped to track historical French samples. The British Association for Shooting and 539 
Conservation (BASC), Amanda Holroyd, Simon Whitehead and all volunteers that 540 
contributed with modern rabbit samples. Peter Kerr provided rabbit samples from 541 
NSW (Australia) from before RHDV. Peter Elsworth and Will Dobbie contributed 542 
Queensland post-RHDV samples. Colin Crump provided human cells lines expressing 543 
VPS4. Rute Fonseca provided valuable advice concerning ancient DNA 544 
bioinformatics. Funding: This work was funded by grants from the Programa 545 
Operacional Potencial Humano±Quadro de Referência Estratégica Nacional funds 546 
from the European Social Fund and Portuguese Ministério da Ciência, Tecnologia e 547 
Ensino Superior to M.C. (IF/00283/2014/CP1256/CT0012), to P.J.E. (IF/00376/2015) 548 
and to J.M.A. (SFRH/BD/72381/2010). J.M.A. was supported by a travel grant from 549 
the Middleton Fund (Cambridge) to undertake work in the Centre of GeoGenetics 550 
(Copenhagen), AM was supported by the European Research Council (grant 647787-551 
LocalAdaptation). FJ was supported by the European Research Council (grant 552 
281668). LL was supported by the European Research Council grant (339941-553 
ADAPT). McFadden Lab is supported by National Institute of Health (NIH) grant 554 
R01 AI080607. S.C.G. holds a Sir Henry Dale Fellowship, co-funded by the 555 
!23 
!
 
Wellcome Trust and the Royal Society (098406/Z/12/Z). Competing interests: None 556 
declared. Author contributions: J.M.A, M.C., P.E., N.F., and F.M.J. designed and 557 
led the study. J.M.A, P.F.C., N.W., S.A., J.P.D and M.T.P.G. generated sequencing 558 
data. J.M.A., T.S., D.J.B, S.J.F, S.M., W.J.P., G.Q., A.K.S. did fieldwork and 559 
extracted DNA.  A.L.M., M.M.R, S.C.G., L.B. and G.M., performed the experiments 560 
in cell culture. J.M.A., M.C., J.Y.C., L.L., A.E., A.M., F.G.V., R.N., and F.M.J. 561 
analysed the data. J.M.A., M.C. and F.M.J. wrote the paper with input from the other 562 
authors. All authors approved the manuscript before submission. Data and materials 563 
availability: Original sequence data are available in the Sequence Read Archive 564 
(www.ncbi.nlm.nih.gov/sra) under BioProject PRJNA393806 (SRP118358). The 565 
variant calls are available in the Cambridge Data Repository 566 
(https://doi.org/10.17863/CAM.35707). French modern samples are available from 567 
S.M. under a material agreement with Office national de la chasse et de la faune 568 
sauvage.  569 
!24 
!
 
Fig. 1 ± Rabbit origins and sampling locations. Historical (circles) and modern 570 
(triangles) sampling locations. Dates in red inside the maps show the date of the first 571 
myxomatosis outbreak in the respective countries. Orange dashed arrows and dates 572 
reflect historical and archaeological records of the colonisation of European rabbits 573 
from France to the United Kingdom and Australia. 574 
Fig. 2 ± Genetic structure and diversity in historical and modern populations of 575 
France, United Kingdom and Australia (a) Principal components analysis (PCA). 576 
Ellipses show 95% confidence intervals. (b) Ancestry fractions inferred with Ohana 577 
structure analysis for K=2 (top) and K=3 (bottom). Each bar shows the inferred 578 
ancestry fraction for an individual. Black lines between bars separate populations. 579 
Labels above bars identify country and labels below bars identify temporal set and 580 
sample size. Individuals are ordered geographically within each population. (c) Decay 581 
of linkage disequilibrium for each population. Each dot represents the averaged 582 
pairwise R
2
 values between pairs of SNPs in non-overlapping 500bp windows. 583 
Colours represent different populations. (d) Expected heterozygosity for each 584 
population. The bars are the mean across chromosome arms, and error bars are 95% 585 
bootstrap confidence intervals from resampling chromosome-arms. Colours represent 586 
different populations. (e) The correlation between the frequency of the alternative 587 
allele in historical and modern populations for France, the UK and Australia. Colours 588 
reflects the relative density of points according to the scale on the bottom right of 589 
each plot, from darker (more density) to lighter (less density). 590 
Fig. 3 ± Parallel changes in allele frequency across three countries. (a) Venn 591 
diagram showing the overlap of the 1000 SNPs with the highest changes in allele 592 
frequency between modern and historical samples (FST) in France, the UK, and 593 
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Australia. Numbers in black show the observed number of SNPs and numbers in red 594 
show the expected overlap after 1000 random permutations of modern and historical 595 
samples within each country. (b) Scaled histogram of the FST values in the three 596 
countries. Bars with dark colours reflect SNPs that are in the top 1000 in both of the 597 
other two countries. Bars with light colours are SNPs that are in the top 1000 of only 598 
one of the other countries. Grey bars are all the remaining SNPs. (c) Genome-wide 599 
selection scan based on allele frequency changes after the introduction of 600 
myxomatosis. (supplementary methods, Equation 5; the strength of selection in each 601 
population is allowed to vary independently) (d) Selection scan testing whether 602 
selection has acted in all three populations (positive values) or just one population 603 
(negative values; supplementary methods, Equation 6). (c and d) Y-axis shows 604 
likelihood ratio statistic of each model. Orange dotted line shows genome-wide 95% 605 
significance threshold from permuting sample collection dates within each country. 606 
Shaded boxes show SNPs located in the highlighted genes. Different shades of blue 607 
show chromosomes. (e) Mean of the posterior distribution of the derived allele 608 
frequency as a function of time for the IFN-Į$ and FCRL3 loci from the Bayesian 609 
selection analysis (additive model). 95% credible intervals are shaded. Triangles 610 
across the bottom represent years of samples (only samples post-1940 are shown). 611 
Dotted lines show dates of first reports of MYXV and RHDV. List of the top 1000 612 
SNPs for all figures is available in Files S2, S3, and S4. 613 
Fig. 4 ± The effect of IFN-Į$ and VPS4 on viral titres. (a and b) wild-type (IFN-614 
Į$JUH\EDUVDQGYDULDQWYDU,)1-Į$\HOORZEDUV IFN-Į$ZHUHDGGHGDW615 
different concentrations to cell culture before infection with (a) MYXV-M029KO and 616 
(b) vesicular stomatitis virus (VSV). Viral titre was measured 1-hour post-infection 617 
(blue bars) and 24/48 hours post infection (orange bars). Error bars show standard 618 
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error of the mean. Statistical significance between wild and mutated interferon 619 
treatments was inferred with a Student's t-test across three replicate assays (* P<0.05; 620 
** P<0.01). (c) HEK293 cell lines stably expressing the wild-type isoform of human 621 
VPS4 (wild-type) or a dominant-negative VPS4 (EQ Mutant) under the control of 622 
ponasterone A (PonA). The HEK293 non-transfected cell line (Parental) was included 623 
as an additional control. Cells were either untreated (PonA-) or pre-treated (PonA+) 624 
with 1 µM PonA for 20-24 hours and then infected with wild-type MYXV expressing 625 
a red fluorescent protein (vMyx-tdTomato) at a multiplicity of infection (MOI) 10. 626 
The percentage of infected cells (tdTomato+) was assessed by flow cytometry. Error 627 
bars show standard error of the mean. (d) Fluorescence microscope images of VPS4 628 
wild-type and VPS4 EQ mutant HEK293 cells pre-treated with PonA (20-24 hours), 629 
48 hours post-infection with vMyx-tdTomato (MOI 10). The live cell images were 630 
taken using an inverted fluorescence microscope at 10x magnification. FFU, focus 631 
forming unit.  632 
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Material and Methods 
Sample collection 
To understand the genomic changes that occurred in the European rabbit (Oryctolagus 
cuniculus) in response to myxoma virus, we studied historical populations prior to the 
beginning of the epizootics, and modern populations from the same locations 
collected more than 50 years after. We focused on three countries where the 
development of genetic resistance to myxomatosis has been described: Australia, 
France and the United Kingdom (6). To mitigate confounding effects caused by 
existing population structure, the study area was restricted to the south of France, 
south of Great Britain, and southeast of Australia (Fig. 1 and Fig. S1). The map layout 
with the sample locations points was generated with the R suite (34) using the 
packages Maps (35) and Mapdata (36). For clarification purposes, the use of the term 
³FRXQWU\´UHIHUVWRWKHFRXQWU\RIRULJLQUHJDUGOHVs of being an historical or modern 
SRSXODWLRQ7KHXVHRIWKHWHUP³SRSXODWLRQ´UHIHUVWRDQKLVWRULFDORUPRGHUQ
population within a country. Sample code names were attributed based on the type of 
sample and location. Each sample is designated by a code of four strings of 
abbreviations connected by an underscore (e.g. M_AU_NSW_bh1). The first string 
states the sample type (M for modern and H for historical), the second refers to the 
country of origin (AU for Australia, FR for France and UK for the United Kingdom), 
the third refers to the state (Australia), department (France) or county (United 
Kingdom), and the fourth string represents the sample location (e.g. city, village) 
followed by the sample number (to distinguish samples collected in the same 
location). 
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7KHKLVWRULFDOVDPSOHVZHUHNLQGO\SURYLGHGE\WKHIROORZLQJ1DWXUDO
+LVWRU\PXVHXPVIURP$XVWUDOLDWKH$XVWUDOLDQ0XVHXPWKH0XVHXP9LFWRULDDQG
WKH4XHHQVODQG0XVHXPIURP)UDQFHWKH0XVpHGHV&RQIOXHQFHVDQGWKH0XVpXP
National d'Histoire Naturelle; from the United Kingdom, the Booth Museum of 
Natural History and the Natural History Museum; and finally from the USA, the 
American Museum of Natural History, the Museum of Comparative Zoology 
(Harvard University), the Museum of Zoology (University of Michigan), and the 
National Museum of Natural History (Smithsonian Institution). We obtained samples 
in the form of bone, skin or residual tissue, belonging to 128 different rabbit 
specimens and collected between 1865 and 1956 (File S1). Six rabbits were collected 
shortly after the release of the virus. Excluding these from the analysis does not affect 
our conclusions. From these, 95 were converted into genomic libraries and sequenced. 
The remaining 33 samples were excluded due to extreme low DNA yields. 
The modern rabbit samples from Australia and France were donated either by 
private hunters or collaborators in the form of purified DNA or tissue (skin clips or 
liver). All the rabbit samples from the United Kingdom were donated by private 
hunters, whose contact was facilitated in most cases by the British Association for 
Shooting and Conservation (BASC). In this case, liver samples were collected directly 
in the field and immediately stored in a falcon tube with absolute ethanol and 
preserved in dry ice. Tissues from all wild rabbits were taken from animals killed for 
recreation or pest controlling purposes by certified hunters. Therefore, no wild animal 
has been killed for the purpose of this study and no animal ethics permit was required. 
When possible, the individual GPS coordinates for each rabbit was taken and animals 
were sexed by visual inspection. The livers were then stored at -80ºC for future DNA 
extraction. Details for each sample, including sex, location and GPS coordinates 
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(when available) are provided in File S1. In total, 78 modern rabbit samples (26 for 
each population), collected between 2002 and 2013, were obtained for this study. 
Rabbit samples between 1985 and 1996 from Australia and the UK were provided by 
collaborators in the form of purified DNA or tissue (liver or blood) (File S1). 
 
DNA extraction from historical and modern samples 
The DNA extraction of the historical samples was conducted at the ancient DNA 
facilities of the Centre for GeoGenetics, Natural History Museum, University of 
Copenhagen. These facilities integrate a set of anti-contamination procedures such as 
positive pressure rooms, ultraviolet light and laminar flow hoods where all sample 
handling is undertaken. The DNA extraction protocol was undertaken in small 
batches of samples, and surfaces were decontaminated with a diluted sodium 
hypochlorite solution and 70% ethanol before and after each batch. 
Two extraction protocols were used according to the type of tissue. For bone, 
prior to the DNA extraction, the samples were ground manually or with a mikro-
dismembrator in case of more compact bone samples. Bone powder was then mixed 
ZLWKȝORI0('7$DQGȝORISURWHLQDVH.VROXWLRQPJPODQGOHIWWR
incubate overnight at 56ºC. The digested sample was then centrifuged at 12,000 rpm 
for 5 min to form a pellet. The liquid portion was re-concentrated to a volume of 200- 
ȝOXVLQJD-kDa cut-off Centricon micron centrifugal filter unit (Millipore, 
Billerica, MA) and centrifuged at 4,000 rpm. DNA was then purified using MinElute 
columns (Qiagen MinElute PCR Purification Kit, Qiagen, Hilden, Germany) 
according to PDQXIDFWXUHU¶VSURWRFROZLWKWKHIROORZLQJPRGLILFDWLRQGXULQJWKH
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elution step, the spin columns with buffer EB were incubated at 37ºC for 15 minutes 
to increase DNA yields. 
For residual dried tissue and skin samples, the hair was removed prior to the 
digestion to prevent blockage of the spin columns during the extraction process, and 
samples cut into smaller pieces to optimise the digestion step. The DNA extraction 
was done with Qiagen DNAeasy Blood and Tissue Kit (Qiagen, Valencia, CA), 
IROORZLQJPDQXIDFWXUHU¶VSURWRFROZLWKWKHIROORZLQJPRGLILFDWLRQGXULQJWKHHOXWLRQ
step, the spin columns with Buffer AE were incubated at 37ºC for 15 minutes to 
increase DNA yields. 
 For modern samples, the genomic DNA was extracted using the Qiagen 
DNAeasy Blood and Tissue Kit (Qiagen, Valencia, CA), following the 
PDQXIDFWXUHU¶VSURWRFRO7KH'1$FRQFHQWUDWLRQRIHDFK'1$H[WUDFWZDVDFFHVVHG
with a Qubit DNA quantification system (Invitrogen, Carlsbad, CA) using Qubit high-
sensitivity assay reagents. 
 
Library Preparation 
The libraries for the historical samples were constructed at the ancient DNA facilities 
of the Centre for GeoGenetics, Copenhagen, Denmark. From the 128 historical 
samples, a set of 95, for which the DNA extraction was successful, was used to make 
genomic libraries.  
)RUHDFKVDPSOHDWRWDORIȝORI'1$H[WUDFWZDVXVHGWRFRQVWUXFWD
double stranded blunt-end Illumina library using NEBNext DNA Sample Prep Master 
Mix Set 2 (New England Biolabs, E6070). The protocol was followed according to 
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the manufacturer's instructions with the following modifications. The reaction volume 
was reduced by a quarter in the end-repair step and by half in the ligation and fill-in 
steps. The end-repair stage was performed for 30 minutes at 20ºC. The ligation 
reaction was performed for 25 min at 20ºC using Illumina-specific adapters specified 
in Meyer and Kircher (37). For both steps, after the incubation, the reaction was 
purified through MinElute spin columns and eluted with a Qiagen EB buffer volume 
RIȝOLQWKHHQG-UHSDLUVWHSDQGȝOLQWKHOLJDWLRQVWHSIROORZHGE\LQFXEDWLRQIRU
15 minutes at 37ºC. The final fill-in reaction was done for 20 minutes at 65ºC. 
To increase library complexity, each library was amplified in two independent 
PCR reactions that were combined in the end. The following protocol was used for 
HDFKȝO3&5UHDFWLRQȝORIXQDPSOLILHGOLEUDU\WHPSODWH8$PSOL7DT*ROG
polymerase (Applied Biosystems, Foster City, CA), 1X AmpliTaq Gold buffer, 2.5 
mM MgCl2, 0.2 mM dN73Vȝ0,OOXPLQD0XOWLSOH[LQJ3&5SULPHULQ3(
SULPHUȝ0,OOXPLQDORQJLQGH[SULPHUPP/RI%RYLQH6HUXP$OEXPLQ
(BSA), and water for the remaining volume. Cycling conditions were: 95.0°C for 10 
min enzyme activation, 8 to 24 cycles of 95.0°C for 30 s, 60.0°C for 1 min, and 
72.0°C for 40 seconds, followed by a final extension of 5 minutes at 72°C (number of 
cycles varied according to each sample and ranged between 8 and 24). The number of 
required amplification cycles was estimated based on the technique described by 
Nathan et al (38). 
The long index primer contained Illumina standard indices from 1 to 24 and a 
set of custom indexes were used for barcoding libraries. The PCR product as purified 
through a single Qiagen MinElute spin column following the manufacturer protocol 
DQGHOXWHGLQȝO(%EXIIHUIROORZLQJDPLQLQFXEDWLRQDW& Following 
7 
!
 
amplification, libraries tested on Agilent 2100 Bioanalyzer High Sensitivity DNA 
chip to evaluate the quality and insert size. Library quantification was undertaken 
using a qPCR KAPA Library Quantification Kit (Kapa Biosystems) according to the 
manufacturer's instructions. 
 For all modern samples, individually barcoded libraries were prepared from 
the purified genomic DNA at TGAC (The Genome Analysis Centre, Norwich, UK) 
using the KAPA LTP Library Preparation Kit for Illumina platforms (KAPA 
%LRV\VWHPV%RVWRQ86$DQGIROORZLQJWKHPDQXIDFWXUHU¶VSURWRFRO$IWHU3&5
amplification, the libraries were quantified using qPCR KAPA Library Quantification 
Kit (KAPA Biosystems, Boston, USA). 
 
Capture design, enrichment and sequencing 
Exome enrichment was performed with NimbleGen solution-based captures 
(NimbleGen SeqCap EZ Developer Library, Roche). The technology is based on the 
development of millions of overlapping 50-105mer probes that cover the target 
region. The technique consists of hybridising the probes with the genomic libraries, 
followed by bead capturing of the complex of capture-oligos and genomic DNA 
fragments, and a final enrichment step of the captured fragments with PCR 
amplification.  
The custom-capture design was based on the coordinates of the gene 
annotations of the OryCun 2.0 rabbit reference genome (Ensembl release 2.69) (39). 
In addition to the coding region, we targeted the mitochondrial genome and three 
regions of the Major Histocompatibility Complex region (MHC) in chromosome 12, 
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encompassing 1.75 Mb (20,160,00 to 21,060,000; 22,290,00 to 22,560,000; 
23,000,000 to 23.580,000). The exact coordinates of targets are available as a BED 
file in the File S7. The targets of interest were provided to Roche Nimblegen for the 
final probe design. All overlapping targets were merged to create a contiguous region, 
and those smaller than 100 bp were padded at both sides to reach a minimum of size 
of 100 bp in order to increase the capture efficiency.  
 The capture-enrichment was undertaken in equimolar pools of individual 
libraries. These pools were made based on the qPCR quantifications and they were 
composed by either historical or modern samples. For the historical pools, samples 
were combined according to their insert size to avoid differential capture 
performance. A total of 21 pools ranging from 6 to 12-plex were made. Exome-
capture was performed on each individual pool using a single capture reaction and 
IROORZLQJWKHPDQXIDFWXUHU¶VSURWRFRO'XHWRWKHXQDYDLODELOLW\RIDUDEELWVSHFLILF
reagent for blocking repetitive regions in the genome at the time, the universal 
SeqCap EZ Developer Reagent Cot-'1$ZDVXVHGIROORZLQJWKHPDQXIDFWXUHU¶V
recommendation. The enrichment and capture of 8 pools was conducted at TGAC 
(Norwich, UK), while the remaining ones at the University of Cambridge. 
 After capture-enrichment, each pool was independently sequenced in one lane 
of HiSeq 2000/2500 Illumina machine using 100bp paired-end reads at TGAC 
(Norwich, UK) and BGI (Beijing Genomics Institute, China). Four of the pools were 
sequenced twice resulting in a total of 25 lanes of HiSeq. 
 
Sanger sequencing of candidate SNPs 
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To investigate if the most extreme changes in allele frequency observed in our dataset 
were caused by MYXV or RHDV, we genotyped SNPs in four of the strongest 
candidate genes/regions (i.e.CD96, FCRL3, IFN-a21A, and MHC region). The 
genotyping was made only for modern samples, before and after RHDV epizootics, 
using PCR followed by Sanger Sequencing using the primers described in Table S3. 
Genotypes are available in File S8. 
 
Bioinformatics and processing of sequencing data 
FastQC, version 0.11.2 (40) was used to evaluate the quality of the raw sequences and 
potential adaptor contamination. Trimmomatic, version 0.32 (41) was used to 
removed low quality bases and adaptor sequences, using the following options: 
TRAILING=15 (cut bases of the end of the read if below a threshold quality of 15), 
SLIDINGWINDOW=4:20 (perform a sliding window trimming, cutting once the 
average quality within the window falls below a threshold of 20), and 
ILLUMINACLIP=TruSeq3-PE.fa:2:20:10:1:true (remove adapter contamination; the 
values correspond in order to: input fasta file with adapter sequences to be matched, 
seed mismatches, palindrome clip threshold, simple clip threshold, minimum adapter 
length and logical value to keep both reads in case of read-through being detected in 
SDLUHGUHDGVE\SDOLQGURPHPRGH7KHWULPPLQJZDVXQGHUWDNHQH[FOXVLYHO\DWWKH¶
end to allow the identification of PCR duplicates (see below). PEAR, version 0.96 
(42), was used to merge overlapping paired-end reads into single-end reads, allowing 
any length size of the assembled sequences. 
The merged and unmerged sequence reads (fastq files) were aligned 
independently to the rabbit reference genome OryCun2.0 using BWA-MEM, version 
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0.7.10 (43) with default options with exception of the parameter ±M, which marks 
shorter split hits as secondary a requirement for Picard compatibility. The generated 
SAM files were converted to their binary format (BAM) and sorted by their leftmost 
coordinates with SAMtools, version 0.1.19 (website: 
http://samtools.sourceforge.net/).Read Group information (RG) was added to the 
BAM files using the module AddOrReplaceReadGroups from Picard Tools, version 
1.126 (https://broadinstitute.github.io/picard).  The module MergeSamFiles in Picard 
was used to merge all BAM files belonging to the same sample, and the module 
MarkDuplicates was used to remove PCR and optical duplicates. Local realignments 
of reads around indels were performed with GATK, version 3.3.0 
(https://www.broadinstitute.org/GATK) using with the tools RealignerTargetCreator 
(determines suspicious intervals which require realignment), and IndelRealigner (runs 
the realigner over those intervals). 
In order to calculate the number of reads mapped on-target we the tool 
intersectBed, from program BEDtools, version 2.22.0 (44) was used to intersect each 
bam file with a BED file containing the interval coordinates of the target regions. The 
average percentage of reads mapped on-target was 63.64% for historical samples and 
50.46% for modern samples. SAMtools Flagstats tool was used to obtain metrics for 
all generated BAM files. GATK module DepthOfCoverage was used to calculate the 
coverage on-WDUJHWZLWKWKHRSWLRQ³LQWHUYDOV´DQGDEHGILOHZLWKWKHFDSWXUH 
coordinates as an input. The mean insert size was inferred with the Picard Tools 
module CollectInsertSizeMetrics. Sequencing metrics for all samples are available in 
File S9. 
A specific problem is cytosine deamination in historical samples, which 
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results LQDQLQFUHDVHRI&ĺ7DQG*ĺ$VXEVWLWXWLRQVDQGWKHUHIRUHDKLJKHU
transition/transversion ratio (45). To mitigate this effect we followed the conventions 
of ancient DNA research and used a Bayesian approach to model DNA damage in 
each sample and reduced base quality scores in the sequence reads to account for the 
effect. The program MapDamage, version 2.06 (46), was used to quantify the damage 
patterns in these samples, followed by downscaling of the quality score of the 
potential post-mortem damaged bases. We used default options with exception of the 
number of reads per sample that was down-sampled to 100,000.  Non-overlapping 
paired-end reads were not rescaled since the option for paired-end reads was not 
integrated in the program. As sites affected by damage-driven mutations would differ 
between samples, we also removed variants that occurred at a low frequency (minor 
allele frequency <0.05 across all individuals in the dataset). This resulted in a 
transition/transversion ratio in the historical populations that was nearly identical to 
modern populations at ~3.3, and similar to that observed in human exomes (6). 
 
Variant calling and filtering 
To avoid potential issues caused by differential mapping of historical and modern 
reads due to their different insert sizes, prior to variant calling we filtered out all reads 
with a mapping quality (MAPQ) below 40. The variant calling was then performed 
for each individual BAM using the HaplotypeCaller tool from GATK. Due to 
computational burden, the variant calling was restricted to the capture-targeted 
regions with a padding of 300bp around each target. We assumed that the 
heterozygosity (proportion of sites that are different from the reference genome) was 
0.004 based on previous studies (16), and all the remaining parameters were kept as 
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default. After obtaining individual gVCF files for each sample, a joint genotyping 
with all historical and modern samples combined was conducted using the tool 
GenotypeGVCFs with default options.  
The resulting raw variant calls (VCF file) went through a set of hard filters to 
remove potential false variants. The following filters were applied: QD < 2.0, FS > 
60.0, MQ < 40.0, MQRankSum < -12.5, ReadPosRankSum < -8.0, where QD is the 
variant confidence (from the QUAL field) divided by the unfiltered depth of non-
reference samples; FS is the phred-scaled p-YDOXHXVLQJ)LVKHU¶V([DFW7HVWWRGHWHFW
strand bias (the variation being seen on only the forward or only the reverse strand) in 
the reads; MQ is the Root Mean Square of the mapping quality of the reads across all 
samples; MQRankSum is the U-based z-approximation from the Mann-Whitney Rank 
Sum Test for mapping qualities (comparing reads with reference bases versus those 
with that have an alternate allele); and ReadPosRankSum is the U-based z-
approximation from the Mann-Whitney Rank Sum Test for the distance from the end 
of the read for reads with the alternate allele (if the alternate allele is only seen near 
the ends of reads, this is indicative of error). 
After obtaining a final VCF file, we applied a filter based on population 
genetics theory, where we removed all positions with a significant excess of 
heterozygotes assuming Hardy-Weinberg equilibrium. This calculation was made 
independently for modern and historical datasets and all significant variants (P < 0.05) 
inferred for the two datasets were removed. The reasoning for this filter is that 
variants with excess of heterozygotes are often a signature of a low mappability 
region where there is a combination of reads correctly and wrongly mapped. Finally, 
we applied a filter at the genotype level with GATK tool VariantFiltration, by keeping 
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only genotypes with a depth of coverage (DP) higher or equal to five and a genotype 
quality (GQ) higher than 20.   
For all the following analyses, we only used samples with a minimum 
coverage on-target of 5x, resulting in final dataset of 152 samples, 75 historical and 
77 modern samples (File S1). The predicted impact, the name of the gene and 
sequence ontology term for each variant was determined using SnpEff, version 4.1 (2, 
17, 18). Human orthologue information, rabbit gene description, and GO Biological 
Process were inferred using Better Bunny online suite, version 2.3 ((19)) (20, 21). 
 
Population Genetic Analyses 
To compare modern and historical populations, we undertook a set of demographic 
analyses. For these analyses, we generated a stricter dataset consisting of biallelic and 
autosomal variants that were contained within the original targets and restricted to 
exons. Additionally, we restricted the analysis to variants that have been called in at 
least 90% of the individuals across all populations. This latter filter was applied with 
VCFtools, version 0.1.12 (47). This resulted in a total of 220,696 SNPs. 
 
Weir & Cockerham's FST 
We quantified genetic differentiation between modern and historical populations for 
each country by calculating the Weir & Cockerham's FST per individual variant (48) 
using VCFtools (47). The global FST values were calculated using the Weir & 
Cockerham's weighted FST estimate as implemented in VCFtools. This analysis was 
restricted to positions with a minimum of 10 individuals for each population and with 
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a minor allele frequency > 0.05 across all individuals. 
To test for parallel evolution we ranked the variants for each country by FST  
value and kept the top 1000 variants. The top 1000 SNPs were then intersected across 
the three countries to count how many of those are common between two countries 
and across all countries. The statistical significance of this intersection was assessed 
by doing 1000 random permutations of historical and modern samples within each 
country. We randomised historical and modern individuals within each country. We 
then calculated the FST  between these mixed populations and took the top 1000 FST 
variants. We repeated this process for each country and then intersected the obtained 
values across the three countries. This process was then repeated 1000 times to 
generate a null distribution. Only variants that were polymorphic in all three countries 
were used in this comparison. 
Changes in Allele Frequency 
To estimate allele frequency for each variant in each population we took the 
individual genotypes of each individual and calculated the allele frequency for the 
reference and alternative allele for each modern and historical population across the 
three countries. To visualise the changes in allele frequency between historical and 
modern populations, we plotted the allele frequency of the reference allele of 
historical against modern populations. For each comparison, we removed all 
monomorphic variants within each country and only used variants with a minimum of 
10 genotypes and a minor allele frequency of 0.05 across all individuals. The plot was 
generated with R software (34) using the heatscatter function in the package LSD 
(49). 
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Ohana Structure and PCA 
To investigate patterns genetic structure, we started by performing a Principal 
Component Analysis (PCA) analysis with Plink2, version 1.02 (50). To further 
explore the genetic structure we used the Structure model (51)  implemented in the 
Ohana tool suite (52). Briefly, Ohana was used to infer global ancestry and the 
covariance structure of allele frequencies among populations. We then modelled the 
joint distribution of allele frequencies across ancestry components as a multivariate 
Gaussian and estimated the population tree that is most compatible with the inferred 
covariance matrix (Fig. S2). For global ancestry and the covariance structure, we 
analysed K values ranging from 2 to 8, where K is the number ancestry components. 
For each value of K, we use 32 independent executions with different random seeds, 
and report the one that reached the highest likelihood. Only variants with a minimum 
of 10 genotypes and a minor allele frequency of 0.05 across all individuals were used. 
Expected heterozygosity 
Expected heterozygosity was inferred for each polymorphic variant in each 
population, and averaged across all variants. Only variants genotyped for all six 
populations were used. To mitigate the effect of damage-driven mutations that could 
increase the number of singletons due to C to T and G to A substitutions, we 
calculated the heterozygosity only for transversions. To obtain confidence intervals 
for the mean of the different chromosome arms, we resampled chromosome arms with 
replacement and recalculated the statistic. 
 
Linkage Disequilibrium 
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To obtain an estimate of linkage disequilibrium for each population we calculated all 
pairwise R
2
 values between pairs of SNPs less than 5Mb apart using Plink2, version 
1.02 (50). Values were then averaged in non-overlapping 500bp windows for plotting. 
Only SNPs with a minor allele frequency of 0.05 were kept. 
 
Selection scan comparing modern and historical samples 
To detect selection, we use a new method which models allele frequency changes 
through time and identifies significant changes in allele frequencies using a likelihood 
ratio test. This method was implemented in a modified version of the software Ohana 
(this modified version can be obtained J.Y.C upon request). The basic model is based 
on the standard Structure model, as shown in Eq 1. Let gij be the genotype for 
individual i in marker j, coded as 0, 1, and 2, indicating homozygous for the major 
allele, heterozygous, and homozygous for the minor allele, respectively. Also, qik is 
the proportion of ancestry of the k¶WKDQFHVWU\FRPSRQHQWLQWKHi¶WKLQGLYLGXDODQGfkj 
is the allele frequency of the major allele in the k¶WKDQFHVWU\FRPSRQHQWIRUWKHj¶WK
marker. Then, the standard log likelihood function is given by: 
ሺD?ሻ ൌ  ?  ? ቀD?H?H?ڄ ൫ ? ൫D?H?H?ڄ D?H�?൯H?H? ൯ ൅ ൫ ? െ D?H?H?൯ ڄ  ቀ ? ቀD?H?H?ڄ ൫ ? െ D?H�?൯ቁH?H? ቁቁH?H?H?H?      (Eq. 1) 
Here I, J, and K indicate the total number of individuals, markers, and ancestry 
components, respectively.  We extended this model to take time-labelled data and 
time-dependent allele frequency changes into account.  Each individual, D?, has had the 
opportunity to change allele frequencies during D?H? time units, indicating the length of 
time from the emergence of the infection to the time of sampling of individual i. We 
then allowed an individual-specific allele frequency, D?H�?H? for each marker D? and each 
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individual D? at each ancestry component D?, and redefine Equation (1) as 
൫D?H?൯ ൌ  ? ቀD?H?H?൫ ? ൫D?H?H?ڄ D?H�?H?൯H?H? ൯ ൅ ൫ ? െ D?H?H?൯  ቀ ? ቀD?H?H?ڄ ൫ ? െ D?H�?H?൯ቁH?H? ቁቁH?H?        (Eq. 2) 
where the individual specific allele frequency now is a function of the time, rescaled 
by the average sampling time, tave, and also depending on a parameter which measures 
the strength of time-dependent allele-frequency change: 
D?H�?H?ൌ  ቀ ?ǡ  ቀ ?ǡ D?H�?HVW ൅ D? ڄH?೔H?H?DYHH?DYH ቁቁ    (Eq. 3) 
Here D? א ൣെ  ൫D?H?HVW൯ ǡ  ? െ  ൫D?H?HVW൯൧ with D?DYH ൌ  ? D?H?H?H? D?ൗ Ǣ D?PRGHUQ ൌ D?PD[and D?ROGHVW ൌ  ?. We used the dates of introduction of the virus as start-of-selection dates, 
i.e. 1952 in France, 1953 in the UK, and 1950 in Australia (2). The parameter D? 
measures the magnitude of allele frequency changes. We use this basic model to 
construct three different models that can be used to test hypotheses about time 
dependent allele frequency change. For each lineage, l, in a population tree, we can 
associate a parameter, D?, which measures the allele frequency change on that lineage. 
In our case, we have three lineages (lineage 1, 2, and 3) with the associated 
parameters D?H?, D?H?, and D?H?. 
In Model 1 (Fig. S3a and Eq. 4), for each marker D?, we constructed a 
likelihood ratio test, where we tested the null hypothesis of D?H?ǣ D?H?ൌ D?H?ൌ D?H?ൌ  ? 
against the alternative hypothesis of D?H?ǣ D?H?ൌ D?H?ൌ D?H?൐  ?. D?ሺD?H?ൌ D?ොǡ D?H?ൌ D?ොǡ D?H?ൌ D?ොሻD?ሺD?H?ൌ  ?ǡ D?H?ൌ  ?ǡ D?H?ൌ  ?ሻ 
(Eq. 4) 
In Model 2 (Fig. S3b and Eq. 5), for each marker we constructed a likelihood 
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ratio test, where we tested the null hypothesis of D?H?ǣ D?H?ൌ D?H?ൌ D?H?ൌ  ? against the 
alternative hypothesis of D?H?ǣ D?H?൐  ?ǡ D?H?൐  ?ǡ D?H?൐  ?, where each scalar is estimated 
separately using maximum likelihood. 
D?ሺD?H?ൌ D?H?ෞǡ D?H?ൌ D?H?ෞǡ D?H?ൌ D?H?ෞሻD?ሺD?H?ൌ  ?ǡ D?H?ൌ  ?ǡ D?H?ൌ  ?ሻ  
    (Eq. 5) 
In Model 3 (Fig. S3c and Eq. 6), for each marker, we constructed a likelihood 
ratio test, where we tested the null hypothesis of D?H?ǣ ሼD?H?H?ǣ D?H?൐  ?ǡ D?H?ൌ D?H?ൌ ?ǢD?H?H?ǣ D?H?൐  ?ǡ D?H?ൌ D?H?ൌ  ?ǢD?H?H?ǣ D?H?൐  ?ǡ D?H?ൌ D?H?ൌ  ?Ǣሽ against the alternative 
hypothesis of D?H?ǣ D?H?ൌ D?H?ൌ  D?H?൐  ?.  D?ሺD?H?ൌ D?ොǡ D?H?ൌ D?ොǡ D?H?ൌ D?ොሻሼD?ሺD?H?ൌ D?H?ෞǡ D?H?ൌ  ?ǡ D?H?ൌ  ?ሻǡ D?ሺD?H?ൌ  ?ǡ D?H?ൌ D?H?ෞǡ D?H?ൌ  ?ሻǡ D?ሺD?H?ൌ  ?ǡ D?H?ൌ  ?ǡ D?H?ൌ D?H?ෞሻሽ Ǥ 
   (Eq. 6) 
Manhattan plots with likelihood values from the selection analyses were plotted with 
the R package qqman (53). We permuted sample collection dates within each country 
1000 times and repeated the analyses above, each time retaining the largest likelihood 
ratio statistic. This gave us a null distribution from which to obtain genome-wide 
significance. 
 
Bayes factor analysis of parallel and population-specific selection 
We examined how often a SNP is under population-specific or parallel selection by 
comparing our selection models using Bayes factors. First, we used the approach 
described above to analyse data from each of the three populations independently to 
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detect SNPs that were under selection (genome-wide significance <0.05 from the 
permutation test). Using the combined dataset of all three populations, we then 
calculated Bates factors (K) in support of selection acting in one (K1), two (K2) or 
three (K3) populations, where: K2 = Pr(Data | selection in two populations)/Pr(Data | 
selection in one populations); K3 = Pr(Data | selection in three populations)/Pr(Data | 
selection in two populations) and K1 = 1/ K2. For a variant initially detected as 
selected in Population1: 
ሺȁ ൌ D?ሺD? ? ൌ D?H?ෞǡ D? ? ൌ  ?ǡD? ? ൌ  ?ሻ  
(Eq. 7) 
ሺȁ ሻ
ൌ D?൫D? ? ൌ D? ?ǡ ?ෞ ǡ D? ? ൌ D? ?ǡ ?ෞ ǡ D? ? ൌ  ?൯ ? ൅ D?൫D? ? ൌ D? ?ǡ ?ෞ ǡ D? ? ൌ  ?ǡ D? ? ൌ D? ?ǡ ?ෞ ൯ ?  
(Eq. 8) 
Pr(Data | selection in three populations) = D?ሺD?H?ൌ D?ොǡ D?H?ൌ D?ොǡ D?H?ൌ D?ොሻ 
(Eq. 9) 
Bayesian allele trajectory analysis 
We used a Bayesian method for inferring the timing and strength of selection from 
ancient DNA genotypes described in Loog et al. (19), where the likelihood of the data 
is a function of the frequency curve of the selected allele in the population and is 
calculated as the product of the probabilities of all observed alleles: 
            D? ൌ  ? D?ሺD?H?ሻH?೔൫ ? െ D?ሺD?H?ሻ൯H?H?H?೔ H?               (Eq. 10) 
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Here L is the likelihood of the data, f(t) is the derived allele frequency at the time t, ti 
is the age of the sample i, and xi is the number of copies of the derived allele observed 
in sample i.  
We used a standard selection model with dominance h of the advantageous 
allele (h = 0, h=1/2 and h=1 corresponds to recessive, additive and dominant effect, 
respectively) and time-dependent selection strength s(t) to describe the allele 
frequency trajectories: 
H?H?H?H?ൌ D?ሺD?ሻD?ሺ ? െ D?ሻሾD? ൅ሺ ? െ ?D?ሻD?ሿ,  (Eq. 11) 
where f is the frequency of the derived allele and s is the selection coefficient. The 
initial value for f(t) is the ancestral frequency (fancestral). We assume that selection 
starts at time tstart and that selection is zero before this time (and, as a consequence, 
that allele frequency is constant at level fancestral). To accommodate change in selection 
through time, we allowed the selection coefficient to change at the time tchange (tchange > 
tstart). The selection coefficient was held constant at level s1 until time tchange, after 
which it was held constant at level s2. 
We assumed that selection began (at time tstart) with the first appearance of the 
myxoma virus (i.e. 1950 in Australia and 1953 in the UK), and then changed (at time 
tchange) when the RHDV virus was reported in the early 1990s (1995 in Australia and 
1992 in the UK). For each combination of country (Australia and UK), gene (MHC, 
IFN-a21A, FCRL3 and CD96), and dominance model (recessive, additive or 
dominant), the remaining model parameters (fancestral, s1 and s2) were inferred by 
making a full parameter sweep where we calculated the deterministic allele frequency 
trajectory for each parameter combination. We assumed a uniform prior for the 
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ancestral frequency (fancestral in the range [0, 1] in steps of 0.01), and the two selection 
coefficients (s1 and s2). We then calculated the marginal posterior probability density 
distribution for each parameter by numerically integrating the likelihood of the data 
over the remaining parameters. In addition, to visualize the inferred allele frequency 
trajectories, we calculated the posterior distribution of the allele frequency trajectory 
through time by weighting the allele frequency trajectory of each parameter 
combination (sampled from their prior distributions) by the likelihood of the data 
given the parameters (19). 
The analysis was implemented in the statistical environment R v. 3.2.2 (34). 
The R code is available from GitHub (https://github.com/LiisaLoog/Rabbit-Selection) 
and from L.L. upon request. The deterministic allele frequency curves were calculated 
using the lsoda function in the R package deSolve v. 1.12 (54). 
 
Interferon-Į$DVVD\V 
We synthesised two N-His6 tagged IFN-Į$ proteins (File S10). The wild type IFN-
Į$ protein sequences matches the Orycun2.0 reference genome. The variant type 
differs in three non-synonymous mutations at coding sequence position 523 (G to A, 
Val175Ile), 542 (G to T, Trp181Leu) and 544 (C to A, Gln182Lys). The codon-
optimised genes were cloned into the vector pUC57 and expressed in yeast (Pichia 
pastoris) by GenScript HK Limited (Piscataway, NJ, USA), and affinity purified.  
Rabbit kidney cell line RK13 was purchased from Sigma, USA (Cat no. 
00021715). RK13-E3 (RK13 cells stably expressing Vaccinia virus E3 protein was 
cultured as described before (22). The cell lines were cultured in DMEM 
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supplemeQWHGZLWK)%6P0JOXWDPLQHDQGȝJRISHQLFLOOLQ-
streptomycin/ml. The cells were maintained at 37
o
C in a humidified 5% CO2 
incubator. Construction of wild-type MYXV, vMyx-GFP (WT-MYXV expressing 
GFP under a poxvirus synthetic early/late promoter) and M029 knockout virus, 
vMyx-M029KO-GFP were described before (22). The construction of vMyx-
M029KO-FLuc-tdTomato virus (M029 knockout virus expressing Firefly luciferase 
under a poxvirus synthetic early/late promoter), and a tandem-dimer tomato red 
fluorescence protein (Tr-FP) driven by poxvirus p11 late promoter) was described 
previously (55). vMyx-M029KO-GFP and vMyx-M029KO-FLuc-tdTomato viruses 
were grown in RK13-E3 cell lines.  
RK13 cells were seeded into 48 well plates at 2x10
4
 cells per well. Next day, 
individual wells were treated with either IFN-Į$ or varIFN-Į$. The IFNs were 
serially diluted 2-fold starting from 4ng/ml in the same DMEM media used for 
JURZLQJFHOOVDQGDGGHGWRWKHZHOOVȝOSHUZHOOUHSODFLQJWKHRULJLQDOPHGLD
Next day, cells were infected with vMyx-GFP, vMyx-M029KO-GFP, VSV-GFP 
viruses at a multiplicity of infection (MOI) of 0.01 in the presence of IFNs. One hour 
after virus adsorption, the media was removed, washed and incubated with the 
respective IFNs containing media. In case of VSV virus, the incubation was with 
DMEM media without any IFNs. The progression of GFP-expressing virus infection 
was monitored using an inverted fluorescence microscope. Cells were harvested 48 
hpi by replacing IFNs containing media with regular DMEM media and stored at -
80
o
C until processed. The cells were freeze-thawed at -80
o
C and 37
o
C for three times 
and sonicated for one minute in ice water to release the viruses from the infected 
cells. vMyx-GFP and vMyx-M029KO-GFP viruses were tittered by serial dilutions 
using RK13 and RK13-E3 cells respectively. The foci were counted 48 hpi. For VSV, 
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virus containing media was collected from each well and stored at -80
o
C until titration 
was done. VSV was tittered by serial dilutions using RK13 cells and agarose overlay 
on the infected cells. The VSV plaques were counted after 24 hpi.   
RK13 cells were seeded into 48 well plates at 2x10
4
 cells per well. Next day, 
the media in each well was replaced with either IFN-Į$ or varIFN-Į$ 
FRQWDLQLQJ'0(0ȝOSHUZHOODIWHUPDNLQJ-fold serial dilutions starting from 
4ng/ml. After over-night incubation, cells were infected with vMyx-M029KO-FLuc-
tdTomato virus at a MOI of 0.01 in the presence of IFNs. After 48 hpi cells were 
washed with 1x PBS and lysed using 1x cell lysis buffer (Promega, USA) for 20 mins 
at room temperature. Luciferase assay reagent was added to the lysate and luciferase 
reading was taken immediately after adding the substrate using a microplate reader. 
 
VPS4 Assays 
Cell lines and viruses: HEK293 cells (Parental) were grown in DulbeccR¶V0RGLILHG
(DJOH¶VPHGLXP'0(09:5/LIH6FLHQFHV5DGQRU3$86$VXSSOHPHQWHG
with 10% FBS (Sigma-Aldrich, St. Louis, MO, USA), 2mM glutamine, 100 U/mL 
streptomycin, and 100 mg/mL penicillin (Gibco, Thermo Fisher Scientific, Waltham, 
MA, USA) (complete DMEM). Ecdysone-responsive stable HEK293 cell lines 
expressing wild-type VPS4 (Wild Type) and dominant-negative VPS4 (EQ mutant) 
(30) were cultured in complete DMEM supplemented with 400 µg/ml Zeocin 
(Invivogen, San Diego, CA, USA) and 800 µg/ml G418 (Caisson Labs, Smithfield, 
UT, USA). All the cells were maintained at 37oC in a humidified 5% CO2 incubator. 
Two myxoma virus constructs, previously described, were used: vMyx- tdTomato, 
expressing the tandem-dimer tomato red fluorescent protein driven by a synthetic 
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early/late poxvirus promoter (56) and vMyx-FLuc-tdTomato, expressing firefly 
luciferase (driven by a synthetic early/late poxvirus promoter) and tomato red (driven 
by poxvirus p11 late promoter) (57). 
Flow cytometry analyses and fluorescence microscopy on HEK293 cells 
(VPS4): HEK293 Parental, Wild Type and EQ mutant cell lines were seeded into 6-
well plates at 5x10
5
 cells per well. On the following day, cells were treated with and 
without 1 µM ponasterone A (ponA) (Santa Cruz Biotechnology, Dallas, TX, USA). 
After 20-24 hours, cells were mock treated or infected with vMyx- tdTomato MOI 10. 
Cells were harvested at 24 and 48 hours post-infection by cell dissociation with 
trypsin. Before harvesting cells at 48 hours post-infection, fluorescence microscopy 
was used to capture live images of infected cells (tdTomato+) on a Leica DMI6000 B 
inverted microscope (LAS X software) at 10x magnification. Sample viability was 
assessed using the Live/Dead® Fixable Near-IR Dead Cell Stain kit (Molecular 
ProbesTM, Thermo Fisher Scientific, Waltham, MA, USA). Infection and cell 
viability data were collected on a BD LSRFortessaTM flow cytometer with BD 
FACSDiva software (BD Biosciences, San Jose, CA, USA). Data were analyzed 
using FlowJo v10 software. A total of three independent experiments was performed, 
and for each experiment the corresponding time points were collected in duplicate. 
Luciferase assay for HEK293 cells (VPS4): HEK293 Parental, Wild Type and 
EQ mutant cell lines were seeded into 12-well plates at 1.5 x10
5
 cells per well. Next 
day, cells were treated with and without 1 µM ponasterone A (ponA) (Santa Cruz 
Biotechnology, Dallas, TX, USA). After 20-24 hours, cells were infected vMyx-
FLuc-tdTomato at a multiplicity of infection (MOI) of 10. Samples were harvested at 
3, 6, 12 and 24 h post-infection by vigorous pipetting, then centrifuged, washed with 
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1x DPBS and preserved as cell pellets at -80ºC until further processing. Before 
performing luciferase assay, cell pellets were lysed using 1x cell culture lysis reagent 
(Promega, Madison, WI, USA) for 20 mins at room temperature. Luciferase assay 
system (Promega, Madison, WI, USA) was used for reporter quantification following 
PDQXIDFWXUHU¶VUHFRPPHQGDWLRQV(DFKVDPSOHZDVTXDQWLILHGLQWULSOLFDWHDQGDWRWDO
of three independent experiments was performed. 
 
MFSD1 Assays 
Cell lines and viruses: RK13 (European rabbit kidney, BVDV negative) cell line 
(Sigma-$OGULFK6W/RXLV0286$ZDVJURZQLQ'XOEHFFR¶V0RGLILHG(DJOH¶V
medium (DMEM, VWR Life Sciences, Radnor, PA, USA) supplemented with 10% 
FBS (Sigma-Aldrich, St. Louis, MO, USA) and 2mM glutamine (Gibco, Thermo 
Fisher Scientific, Waltham, MA, USA). Construction of vMyx-FLuc-tdTomato 
expressing firefly luciferase was described before (Zemp). 
Custom siRNAs were custom designed with dTdT overhang at Dharmacon 
(United Kingdom. The designs are available in Table S4. siRNA transfection and 
luciferase assay on RK13 cells (MFSD1): RK13 cell line was used to screen for eight 
different small interfering RNA (siRNA) duplexes targeting European rabbit MFSD1 
(Dharmacon, Lafayette, CO, USA). A functional siRNA against Luciferase was used 
as a control, FLuc-S1 Positive Control DsiRNA (IDT, Coralville, IA, USA). Cells 
were plated at 30-40 % confluence per well of a 48-well plate a day before 
transfection with targeting siRNA, each at a 50 nM concentration, using 
Lipofectamine RNAiMAX (Invitrogen, Thermo Fisher Scientific, Waltham, MA, 
USA). After 48 hours, cells were infected with vMyx-FLuc-tdTomato at an MOI 3. 
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After 1 hour of virus adsorption, cells were washed with 1x DPBS and fresh media 
was added. At 24 hours post-infection, cells were washed with 1x DPBS and collected 
by scrapping. Cell pellets were preserved at -80ºC until further processing. Later, 
pellets were lysed using 1x cell culture lysis reagent (Promega, Madison, WI, USA) 
for 20 mins at room temperature before performing the luciferase assay (Promega, 
0DGLVRQ:,86$IROORZLQJPDQXIDFWXUHU¶VUHFRPPHQGDWLRQV(DFKVDPSOHZDV
quantified in triplicate and a total of three independent experiments was performed. 
siRNA transfection cytotoxicity on RK13 cells (MFSD1): To measure cell 
viability (cytotoxicity assay) following siRNA transfection, CellTiter 96® AQueous 
One Solution Cell Proliferation Assay (MTS) was purchased from Promega 
(Madison, WI, USA). siRNA transfection (adjusted to a 96-well plate), duration and 
concentration were applied as previously described. After 48 hours of siRNA 
delivery, the tetrazolium substrate (MTS) was added to RK13 cells and the A490 
formazan product that is produced in viable cells was measured using a microplate 
reader after 1 hour of incubation. Each sample was quantified in triplicate and a total 
of three independent experiments was performed. 
 Fig. S1 ± Map of sample locations in Australia, France and United Kingdom. 1 
Maps correspond to our study area for historical (left) and modern (right) samples. 2 
Dots and names show sample locations. Locations in bold have more than one 3 
sample. 4 
  5 
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Fig. S2 ± Ancestry proportions and trees estimates inferred with Ohana from 6 
K=2 until K=8. On the left, ancestry proportions where each bar shows the inferred 7 
ancestry fraction for an individual. The black lines between bars separate populations. 8 
Labels on the top identify country, temporal set, sample size and individuals. 9 
Individuals are ordered geographically within each population. On the right, 10 
population trees for the ancestry components that are most compatible with the 11 
inferred covariance matrix for each respective value of K. Branch length is an 12 
indication of drift. 13 
29 
!
 
  14 
30 
!
 
Fig. S3 ± Models implemented in Ohana. (a). In Model 1, we test the null 15 
hypothesis of H?ǣ ȽH?ൌ ȽH?ൌ ȽH?ൌ  ? against the alternative hypothesis of H?ǣ ȽH?ൌ16 ȽH?ൌ ȽH?൐  ?. (b). In Model 2, we test the null hypothesis of H?ǣ ȽH?ൌ ȽH?ൌ ȽH?ൌ  ? 17 
against the alternative hypothesis of H?ǣ ȽH?൐  ?ǡ ȽH?൐  ?ǡ ȽH?൐  ?. (c). In Model 3, we 18 
test the null hypothesis of H?ǣ ሼH?H?ǣ ȽH?൐  ?ǡ ȽH?ൌ ȽH?ൌ  ?ǢH?H?ǣ ȽH?൐  ?ǡ ȽH?ൌ ȽH?ൌ19  ?Ǣ H?H?ǣ ȽH?൐  ?ǡ ȽH?ൌ ȽH?ൌ  ?Ǣሽ against the alternative hypothesis of H?ǣ ȽH?ൌ ȽH?ൌ20 ȽH?൐  ?. 21 
 22 
  23 
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 24 
Fig. S4 ± Genome-wide selection scan based on allele frequency changes after the 25 
introduction of MYXV. Selection is assumed to be the same across the three 26 
countries (Equation 4, supplementary methods) Y-axis shows likelihood ratio values 27 
for the tested model. The orange dotted line shows the genome-wide 95% 28 
significance, which was derived by threshold from permuting sample collection dates 29 
within each country. Shaded boxes show SNPs located in the highlighted genes. 30 
Different shades of blue show chromosomes.  31 
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Fig. S5 - Genome-wide scan for selection in individual populations with SNPs 33 
coloured according to evidence of parallelism or population-specific selection. 34 
The horizontal dotted line shows genome-wide 95% significance threshold from 35 
permuting sample collection dates within each country. For SNPs above the 36 
significant threshold dotted line, those coloured in blue are inferred to be under 37 
selection only in that population (Bayes factor >= 3). SNPs coloured in orange and 38 
red are inferred to be under selection either in two or the three populations, 39 
respectively (Bayes factor >= 3). Different shades of grey show chromosomes. Note 40 
all SNPs are shown, not just the most significant SNP per gene. 41 
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 43 
 44 
Fig. S6 ± Effect of IFN-Į$, VPS4 and MFSD1 on viral titre. (a)Viral titre 45 
measured after 1 hour of infection (blue bars) and after 24/48 hours (orange bars), and 46 
after treatment with different concentrations of the wild type IFN-Į$JUH\EDUV47 
and variant varIFN-Į$\HOORZEDUV for MYXV wild type (vMyx-GFP). Error bars 48 
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show standard error of the mean. Statistical significance between wild and variant 49 
interferon on viral titer was tested with a Student's t-test across the three replicates (* 50 
P<0.05; ** P<0.01). (b) Viral gene expression inferred with a luciferase essay for 51 
IFN-Į$JUH\EDUVDQGYDULDQWYDU,)1-Į$\HOORZEDUV for myxoma virus 52 
(vMyx-M029KO-FLuc-TdTomato) at different concentrations. Error bars show 53 
standard error of the mean. (c) Myxoma virus gene expression on infected HEK293 54 
ecdysone-responsive stable cell lines expressing wild-type VPS4 (Wild Type), 55 
dominant-negative VPS4 (EQ Mutant), and on infected control cell line (Parental, no 56 
transfection) was evaluated by using a recombinant virus expressing firefly luciferase 57 
(vMyx-FLuc-tdTomato). Cells were either kept untreated (PonA-) or pre-treated 58 
(PonA+) with 1 µM PonA for 20-24 hours, followed by infection at multiplicity of 59 
infection (MOI) 10. At 3, 6, 12 and 24 hours post-infection cells were collected and 60 
luciferase assay was performed. Error bars show standard error of the mean. (d) 61 
Fluorescence microscope images of VPS4 Wild Type and EQ mutant HEK293 cells 62 
treated with and without PonA (PonA+ and PonA-, respectively), 48 hours after 63 
infection with wild-type myxoma virus expressing a red fluorescent protein (vMyx-64 
tdTomato) at MOI 10. Red fluorescence and phase contrast images of live cells were 65 
collected 48 hours post-infection using an inverted fluorescence microscope at 10x 66 
magnification. (e) Effect of MFSD1 on MYXV titre using luciferase. The expression 67 
of MFSD1 was knocked down using eight different siRNAs in rabbit RK13 cells. 68 
The negative control had no siRNAs, and the positive control had an siRNA against 69 
luciferase. Cells were infected with vMyx-FLuc-tdTomato at an MOI 3, and viral 70 
titres measured by luciferase fluorescence 24 and 48 hours post infection. The results 71 
of three independent biological replicates of each treatment are shown. Viral titres are 72 
normalised to the control. 73 
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Fig. S7 ± Structure of the CD200:CD200R complex. (a) The structure of the mouse 75 
CD200:CD200R complex (PDB ID 4BFI (23)) is shown as ribbons. Mouse CD200 76 
and CD200R share high sequence identity with their rabbit homologues (78% and 77 
53% across their structured ectodomains, respectively) and the CD200R binding 78 
interface of CD200 is strongly conserved across mammals (23), suggesting that the 79 
rabbit CD200:CD200R interaction will closely resemble the mouse complex. (b) 80 
Sequence alignment of mature mouse and rabbit CD200R. Residues of mouse 81 
CD200R that interact with CD200 are starred, and the site of the rabbit CD200R non-82 
synonymous variant (isoleucine to threonine) that is selected in the French population 83 
is highlighted. Alignment was generated using Clustal Omega (58) and illustrated 84 
using ALINE (59) (c) Surface representation of the CD200R, with the CD200-binding 85 
interface of CD200R outlined. Mouse CD200R residue S57, equivalent to residue 86 
under selection in the French population, is highlighted. Molecular images were 87 
generated using PyMOL (Schrödinger LLC). 88 
  89 
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Table S1 ± Global Fixation Index (FST) estimated between population pairs. Only 90 
polymorphic loci and a minimum of 10 individual genotypes were used for each two-91 
population comparison. 92 
 93 
Comparison Population 1 Population 2 Variants Mean FST 
Historical versus 
Modern 
France  France  424,922 0.020 
United Kingdom  United Kingdom  466,141 0.009 
Australia  Australia  345,335 0.014 
Historical versus 
Historical 
France  Australia  370,971 0.142 
France  United Kingdom  416,041 0.128 
United Kingdom  Australia  367,526 0.067 
Modern versus 
Modern 
France  Australia  887,287 0.095 
France  United Kingdom  968,815 0.085 
United Kingdom  Australia  850,659 0.060 
  94 
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Table S2 ± Frequency of the selected allele of SNPs under population-specific 95 
selection. 96 
 97 
  Mean frequency in 
Historical Population
2 
Population selection detected in
1 
N Australia France UK 
Australia 9 0.05 0.10 0.12 
France 9 0.12 0.07 0.09 
United Kingdom 2 0.00 0.00 0.04 
 98 
1 Variants were identified as having experienced a significant change in frequency since the release of the myxoma 99 
virus (genome-wide p<0.05 when each population analysed separately) and having evidence for population 100 
specific selection (Bayes factor >3 when comparing a model of selection in 1 population with a model of selection 101 
in 2 populations). Within each gene region only the most significant SNP was retained. 102 
 103 
2 The mean frequency of the SNPs among historical samples. The frequency in the population where selection has 104 
acted is highlighted in bold105 
 Table S3 ± Sanger sequencing primer sequences used for genotyping variants at genes/regions CD96, FCRL3, IFN-Į$, MHC, PSMG3. 106 
 107 
Gene/Region Chromosome Position Primer Forward Primer Reverse Fragment Size (bp) 
CD96 14 107622993 GGATCTGTAATGTACTTAAGTGACTGG GATACTACCCTAATGCAAGGAGTC 158 
FCRL3 13 35513450 CTCTGAGGCCCGGACTGT AGGCCATTGTCAGCCTCA 167 
IFNA21A 1 32518812 GCTGTGAGGAAATACTTCCAAGG CAGGAATCATTTTATGTTGGTCCT 128 
MHC 12 20266487 GAGCCTGAGACCTCATCCAG TGTTCAGAGAGCCCCAACAT 464 
PSMG3 3 - GGACTGCGGGTCTCTTGTC CACTGCTCCTGTCCTTCACA 429 
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Table S4 ± siRNAs for MFSD1 gene. 109 
 110 
siRNA Chromosome Position siRNA (Sense) siRNA (Antisense) Target Sequence 
MFSD1 14 1278 GUUUGUAGUUCCUGAGCAUdTdT AUGCUCAGGAACUACAAACdTdT GTTTGTAGTTCCTGAGCAT 
MFSD2 14 394 CUGUAUGCCUGGUAUUCUUdTdT AAGAAUACCAGGCAUACAGdTdT CTGTATGCCTGGTATTCTT 
MFSD3 14 628 GUGAGUUGGUUUAAAGGCAdTdT UGCCUUUAAACCAACUCACdTdT GTGAGTTGGTTTAAAGGCA 
MFSD4 14 955 GUCAUCUGUGUCUGCUAUUdTdT AAUAGCAGACACAGAUGACdTdT GTCATCTGTGTCTGCTATT 
MFSD5 14 754 GGUUCUGCUGGUCAUACAAdTdT UUGUAUGACCAGCAGAACCdTdT GGTTCTGCTGGTCATACAA 
MFSD6 14 366 GCAGGUGAAUACCACGAAAdTdT UUUCGUGGUAUUCACCUGCdTdT GCAGGTGAATACCACGAAA 
MFSD7 14 1048 GCAAGUGCAAUUAACAGUAdTdT UACUGUUAAUUGCACUUGCdTdT GCAAGTGCAATTAACAGTA 
MFSD8 14 694 GCAGUACAGUAAACAUGAAdTdT UUCAUGUUUACUGUACUGCdTdT GCAGTACAGTAAACATGAA 
  111 
 Additional Supplementary Material (Separate Files)  
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File S2 ± List containing the top 1000 SNPs based on FST for each population. 113 
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File S4 ± List containing the top 1000 SNPs based on Ohana (Population-specific). 115 
File S5 ± Bayes factors for most significant SNP per gene (Population-specific). 116 
File S6 ± Likelihood ratios and parameter estimation for SNP trajectories over time. 117 
File S7 ± BED file with probe coordinates for the exome capture. 118 
File S8 ± Sanger and exome-sequencing genotypes for pre-myxomatosis, pre-RHDV 119 
and post-RHDV samples for four SNPs located at IFN-Į$, FCRL3, CD96 genes 120 
and at the MHC region. Sanger sequencing genotypes of four SNPs, one insertion, 121 
and one deletion, located in PSMG3 gene for 68 modern individuals from Australia, 122 
France, the UK and the rabbit cell line RK13.  123 
File S9 ± Sequencing metrics for exome sequencing data. 124 
File S10 ± Wild type and variant Interferon-Į$ (IFN-Į$ protein sequences. 125 
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